No. of studies |
23b
|
No. of patients |
1243 |
Study type, n |
|
Retrospective case series |
12 |
Randomized controlled trials |
3 |
Retrospective comparative studies |
3 |
Prospective comparative studies |
2 |
Prospective case series |
2 |
Retrospective cohort studies |
1 |
Follow-up duration,c mo |
16-144 |
Defects (n = 1185), n (%) |
|
Primary |
1143 (96) |
Secondary |
42 (4) |
Berndt and Harty classification (n = 361), n (%) |
|
Stage I |
47 (13) |
Stage II |
155 (43) |
Stage III |
119 (33) |
Stage IV |
40 (11) |
RTS rate (n = 389),c mean (95% CI), % |
76-100 (67-100) |
RTS rate to preinjury level (n = 195),c mean (95% CI), % |
18-100 (6-100) |
Time to RTS (n = 215),c wk |
15-26 |